Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02404454 |
Recruitment Status : Unknown
Verified March 2016 by Stefano Angioni, University of Cagliari.
Recruitment status was: Not yet recruiting
First Posted : March 31, 2015
Last Update Posted : March 9, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The septate uterus is the most common structural uterine anomaly. It results from failure of the partition between the two fused Müllerian ducts to resorb;it is associated with the highest incidence of reproductive failure and with first- and second-trimester pregnancy loss and infertility.
Hysteroscopic division of the uterine septum is performed using microscissors, electrosurgery, or laser. Several studies shown significant improvement in pregnancy outcome after hysteroscopic metroplasty.
Purpose of this study is to verify the effectiveness of 5 ml, instead of 10 ml, of autocross-linked hyaluronic acid gel in the prevention of the formation of intrauterine adhesions, through second look office hysteroscopy after three months.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Intrauterine Adhesions Septate Uterus | Procedure: Hysteroscopic metroplasty Device: Autocross-linked acid hyaluronic gel Procedure: Office second look hysteroscopy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 50 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Study Start Date : | June 2016 |
Estimated Primary Completion Date : | December 2016 |
Estimated Study Completion Date : | March 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: hysteroscopic metroplasty
women undergoing hysteroscopic metroplasty for uterine septum resection
|
Procedure: Hysteroscopic metroplasty Device: Autocross-linked acid hyaluronic gel Patients received adhesion barrier with 5 ml of autocross-linked acid hyaluronic gel Procedure: Office second look hysteroscopy Second-look hysteroscopy after three months |
- Change in Formation of intrauterine adhesions [ Time Frame: baseline (operative isteroscopy and three months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- uterine septum
- history of ≥1 miscarriage or infertility;
- desire to have children in the future
Exclusion Criteria:
- pregnancy;
- menopause;
- precancerous state or malignancy of the reproductive organs;
- benign lesions in the myometrium of the uterine fundus (myomas or adenomyosis)
- lesions distorting the uterine cavity (submucosal myomas or intrauterine adhesions) on ultrasonography;
- withdrawal of patient consent;
- rare complex uterine congenital anomalies without an ASRM classification such as uterine septum with double cervix ;
- presence of external intercornual cleft;
- incomplete (internal fundal indentation 10 mm) or non-standardized septum resection (internal fundal indentation ,10 mm and uterine myometrial thickness .10 mm at the fundus), confirmed intraoperatively
- excessive fundal incision (uterine myometrial thickness ,6 mm at the fundus confirmed intraoperatively)
Responsible Party: | Stefano Angioni, Associate Professor, University of Cagliari |
ClinicalTrials.gov Identifier: | NCT02404454 |
Other Study ID Numbers: |
MulticentricMetroplasty |
First Posted: | March 31, 2015 Key Record Dates |
Last Update Posted: | March 9, 2016 |
Last Verified: | March 2016 |
Tissue Adhesions Cicatrix Fibrosis Pathologic Processes Hyaluronic Acid |
Adjuvants, Immunologic Immunologic Factors Physiological Effects of Drugs Viscosupplements Protective Agents |